Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

Christian P. Bradley; Cai Chen; Karolyn A. Oetjen; Cheng Yan; Reema Panjwani; Sara Hauffe; Katherine R. Calvo; Constance Yuan; Prapti Arvind Patel; Nathan D. Montgomery; Matthew C. Foster; Minoo Battiwalla; A. John Barrett; Richard J. Gibbons; Sawa Ito

doi:10.1182/bloodadvances.2019000013

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

Christian P. Bradley, Cai Chen, Karolyn A. Oetjen, Cheng Yan, Reema Panjwani, Sara Hauffe, Katherine R. Calvo, Constance Yuan, Prapti Arvind Patel, Nathan D. Montgomery, Matthew C. Foster, Minoo Battiwalla, A. John Barrett, Richard J. Gibbons, Sawa Ito

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	2627-2631
Number of pages	5
Journal	Blood Advances
Volume	3
Issue number	17
DOIs	https://doi.org/10.1182/bloodadvances.2019000013
State	Published - Sep 10 2019

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2019000013

Cite this

Bradley, C. P., Chen, C., Oetjen, K. A., Yan, C., Panjwani, R., Hauffe, S., Calvo, K. R., Yuan, C., Patel, P. A., Montgomery, N. D., Foster, M. C., Battiwalla, M., Barrett, A. J., Gibbons, R. J., & Ito, S. (2019). Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier. Blood Advances, 3(17), 2627-2631. https://doi.org/10.1182/bloodadvances.2019000013

Bradley, CP, Chen, C, Oetjen, KA, Yan, C, Panjwani, R, Hauffe, S, Calvo, KR, Yuan, C, Patel, PA, Montgomery, ND, Foster, MC, Battiwalla, M, Barrett, AJ, Gibbons, RJ & Ito, S 2019, 'Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier', Blood Advances, vol. 3, no. 17, pp. 2627-2631. https://doi.org/10.1182/bloodadvances.2019000013

@article{7ca04bcaf121464dbf5c42aefcbecc78,

title = "Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier",

author = "Bradley, {Christian P.} and Cai Chen and Oetjen, {Karolyn A.} and Cheng Yan and Reema Panjwani and Sara Hauffe and Calvo, {Katherine R.} and Constance Yuan and Patel, {Prapti Arvind} and Montgomery, {Nathan D.} and Foster, {Matthew C.} and Minoo Battiwalla and Barrett, {A. John} and Gibbons, {Richard J.} and Sawa Ito",

note = "Funding Information: Conflict-of-interest disclosure: N.D.M. received research and travel funding from Ventana Biosystems and collaborated on research with ArcherDx. M.C.F. received an honorarium from Shire Plc and a grant from Bellicum Pharmaceuticals, and his institution received fees from Novartis Pharmaceuticals and Amgen Inc. P.A.P. received honoraria from DAVA Pharmaceuticals, served in a consulting or advisory role for France Foundation, and was a member of the speaker{\textquoteright}s bureau for Celgene. The remaining authors declare no competing financial interests.",

year = "2019",

month = sep,

day = "10",

doi = "10.1182/bloodadvances.2019000013",

language = "English (US)",

volume = "3",

pages = "2627--2631",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "17",

}

TY - JOUR

T1 - Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

AU - Bradley, Christian P.

AU - Chen, Cai

AU - Oetjen, Karolyn A.

AU - Yan, Cheng

AU - Panjwani, Reema

AU - Hauffe, Sara

AU - Calvo, Katherine R.

AU - Yuan, Constance

AU - Patel, Prapti Arvind

AU - Montgomery, Nathan D.

AU - Foster, Matthew C.

AU - Battiwalla, Minoo

AU - Barrett, A. John

AU - Gibbons, Richard J.

AU - Ito, Sawa

N1 - Funding Information: Conflict-of-interest disclosure: N.D.M. received research and travel funding from Ventana Biosystems and collaborated on research with ArcherDx. M.C.F. received an honorarium from Shire Plc and a grant from Bellicum Pharmaceuticals, and his institution received fees from Novartis Pharmaceuticals and Amgen Inc. P.A.P. received honoraria from DAVA Pharmaceuticals, served in a consulting or advisory role for France Foundation, and was a member of the speaker’s bureau for Celgene. The remaining authors declare no competing financial interests.

PY - 2019/9/10

Y1 - 2019/9/10

UR - http://www.scopus.com/inward/record.url?scp=85072206256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072206256&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2019000013

DO - 10.1182/bloodadvances.2019000013

M3 - Article

C2 - 31501157

AN - SCOPUS:85072206256

SN - 2473-9529

VL - 3

SP - 2627

EP - 2631

JO - Blood Advances

JF - Blood Advances

IS - 17

ER -

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this